CA2158345A1 - Recepteur adrenergique humain de type alpha 1c, clone - Google Patents

Recepteur adrenergique humain de type alpha 1c, clone

Info

Publication number
CA2158345A1
CA2158345A1 CA 2158345 CA2158345A CA2158345A1 CA 2158345 A1 CA2158345 A1 CA 2158345A1 CA 2158345 CA2158345 CA 2158345 CA 2158345 A CA2158345 A CA 2158345A CA 2158345 A1 CA2158345 A1 CA 2158345A1
Authority
CA
Canada
Prior art keywords
alpha
receptor
leu
adrenergic receptor
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2158345
Other languages
English (en)
Inventor
Marvin L. Bayne
Bradley V. Clineschmidt
Catherine D. Strader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2158345A1 publication Critical patent/CA2158345A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA 2158345 1993-03-15 1994-03-10 Recepteur adrenergique humain de type alpha 1c, clone Abandoned CA2158345A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3284993A 1993-03-15 1993-03-15
US032,849 1993-03-15

Publications (1)

Publication Number Publication Date
CA2158345A1 true CA2158345A1 (fr) 1994-09-29

Family

ID=21867151

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2158345 Abandoned CA2158345A1 (fr) 1993-03-15 1994-03-10 Recepteur adrenergique humain de type alpha 1c, clone

Country Status (5)

Country Link
EP (1) EP0689547A4 (fr)
JP (1) JPH08508163A (fr)
AU (1) AU685789B2 (fr)
CA (1) CA2158345A1 (fr)
WO (1) WO1994021660A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861309A (en) * 1992-09-25 1999-01-19 Synaptic Pharmaceutical Corporation DNA endoding human alpha 1 adrenergic receptors
US5403847A (en) * 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
US6015819A (en) 1992-11-13 2000-01-18 Synaptic Pharmaceutical Corporation Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
US5578611A (en) * 1992-11-13 1996-11-26 Synaptic Pharmaceutical Corporation Use of α-1C specific compounds to treat benign prostatic hyperplasia
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
US5661163A (en) * 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
US5620993A (en) * 1995-06-07 1997-04-15 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
US5807856A (en) * 1995-11-15 1998-09-15 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
EP1775311B1 (fr) * 2004-08-04 2018-09-05 Sekisui Chemical Co., Ltd. Procédé pour produire une résine d'acétal de polyvinyle
WO2006021344A1 (fr) * 2004-08-27 2006-03-02 Bayer Healthcare Ag Diagnostic et traitement de maladies associees au recepteur adrenergique alpha-1a (adra1a)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history
EP0649431B1 (fr) * 1992-05-20 1999-08-11 Merck & Co. Inc. Inhibiteurs de 5-alpha-reductase a base de 4-azasteroides a substitution amino en position 17
WO1994008040A1 (fr) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Adn codant des recepteurs adrenergiques alpha 1 humains et leurs utilisations
US5403847A (en) * 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia

Also Published As

Publication number Publication date
EP0689547A1 (fr) 1996-01-03
AU685789B2 (en) 1998-01-29
WO1994021660A1 (fr) 1994-09-29
EP0689547A4 (fr) 1998-10-28
JPH08508163A (ja) 1996-09-03
AU6445394A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
US5652113A (en) DNA encoding a human 5-HT 1F receptor and uses thereof
AU685076B2 (en) DNA encoding 5-HT4 serotonin receptors and uses thereof
Lake et al. Cloning of the rat and human prostaglandin F2α receptors and the expression of the rat prostaglandin F2α receptor
US5654139A (en) Allelic variation of the serotonin 5HT2c receptor
JPH10510709A (ja) 摂食行動を変える方法、該方法に有用な化合物、および視床下部の異型神経ペプチドｙ／ペプチドｙｙ受容体（ｙ５）をコードするｄｎａ
HUT76969A (hu) Glutamát receptor
CA2158345A1 (fr) Recepteur adrenergique humain de type alpha 1c, clone
EP0769024B1 (fr) Yrecepteurs de la melatonine de haute affinite et leurs utilisations
AU678266B2 (en) Opioid receptors: compositions and methods
EP0666915A1 (fr) Recepteur de serotonine pct-65
WO2000031262A2 (fr) Recepteur sous-type 2 humain de la neurotensine
US6750322B2 (en) Guanosine triphosphate (GTP) binding protein-coupled receptor proteins
JP2004500085A (ja) ヒトバニロイドレセプターｖｒ３をコードするｄｎａ
EP0668912B1 (fr) RECEPTEUR DE SEROTONINE St-B17
CA2147839C (fr) Le recepteur a serotonine st-b17
AU667510C (en) DNA encoding a human 5-HT-1F receptor and uses thereof
US7081349B1 (en) High-affinity melatonin receptor and uses thereof
US20020081661A1 (en) DNA encoding 5-HT4 serotonin receptors and uses thereof
Gerald et al. DNA encoding 5-HT4A serotonin receptors
JPH10117791A (ja) ヒトｇタンパク質結合受容体ｈｌｙａｚ６１
Lappalainen et al. Allelic variation of the serotonin 5HT 2c receptor
Gill Adipose tissue expression, alternative splicing, desensitization and internalization of the glucose-dependent insulinotropic polypeptide receptor

Legal Events

Date Code Title Description
FZDE Dead